Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advances in qPCR and dPCR

Florent Mouliere's Biography



Florent Mouliere, Researcher, Nitzan Rosenfeld Group, University of Cambridge

Florent is a postdoctoral researcher at the Cancer Research UK Cambridge Institute, University of Cambridge. He received his Msc. in bioengineering from the Ecole des Mines d’Ales and a Ph.D. in molecular biology from the University of Montpellier, France. He joined Nitzan Rosenfeld's Laboratory at the University of Cambridge at the end of 2013. His interests are tailoring new sequencing technologies and multi-omics analysis to study the biology of circulating nucleic acids. These methods will improve the sensitivity of liquid biopsy in difficult pathological contexts (early detection, MRD and brain tumours) and expand the utility of ctDNA to new clinical applications.

Florent Mouliere Image

Determination and Follow-up of a Mutational Profile with Circulating Tumour DNA Analysis

Wednesday, 14 May 2014 at 16:30

Add to Calendar ▼2014-05-14 16:30:002014-05-14 17:30:00Europe/LondonDetermination and Follow-up of a Mutational Profile with Circulating Tumour DNA AnalysisAdvances in qPCR and dPCR in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

Circulating tumour DNA (ctDNA) exhibits the same genetic alterations from its tumour of origin, and can be used as a “liquid biopsy” for monitoring tumour progression. Q-PCR, digital PCR and next-generation sequencing are technologies of choice for determining and following-up a mutational profile with ctDNA.


Add to Calendar ▼2014-05-14 00:00:002014-05-15 00:00:00Europe/LondonAdvances in qPCR and dPCRAdvances in qPCR and dPCR in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com